CureVac has today suffered a defeat in its dispute against BioNTech over mRNA patents, after the German Federal Patent Court nullified the German part of an important patent. The decision will affect
FRANKFURT, Nov 21 (Reuters) - The European Patent Office declared a contested mRNA patent owned by Moderna (MRNA.O) invalid, the office said on Tuesday, handing a win to BioNTech (22UAy.DE) and its
mRESVIA vaccines (among others) are infringing their mRNA-related patents in 30 different countries. The companies have filed lawsuits in the Federal Court of Canada, the Tokyo District Court
total 1 pages, 3 items